Physician profile
Christina C Moore
NPI 1962848945
$26,266.07
in general payments reported to CMS, 2019-2025
11 companies · $19K in 2025
The $19K reported for 2025 was more than what 96% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $136 · 2021: $234 · 2022: $5,098 · 2023: $417 · 2024: $1,150 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,200 · Travel and Lodging: $2,815 · Food and Beverage: $2,647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,200.00 |
| Travel and Lodging | $2,815.27 |
| Food and Beverage | $2,647.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $13,841.89 | 2023-2025 | Sprint Pns System |
| Medtronic, INC. | $9,643.83 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Spinal Simplicity, LLC | $1,054.66 | 2024-2025 | Ha Minuteman G3-R, Patriot Si |
| Nevro Corp. | $496.52 | 2019-2023 | Senza |
| Abbott Laboratories | $415.14 | 2019-2025 | Proclaim |
| Boston Scientific Corporation | $329.72 | 2021-2025 | General - Therapies, Watchman Access System, Intracept |
| Vertos Medical, INC. | $130.77 | 2022 | |
| Grt US Holding, INC. | $129.73 | 2022 | |
| Biotronik Nro, INC. | $127.39 | 2025 | Prospera |
| Johnson & Johnson Vision Care, INC. | $65.53 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $30.89 | 2025 | Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.